Isoray, Inc., operating through its subsidiary IsoRay Medical, Inc., specializes in the development, production, and sale of isotope-based medical devices and products. These offerings are designed for the treatment of cancer and other malignant diseases, distributed across both the United States and international markets. A key product is their CS-1 Cesium-131 brachytherapy seeds, utilized in addressing a variety of cancers, including those of the prostate, brain, lung, head and neck, as well as gynecological, pelvic/abdominal, and colorectal malignancies. The company distributes its products to medical facilities or physician practices that conduct surgical operations. Founded in 1998, Isoray, Inc. is headquartered in Richland, Washington.


Net sales
Gross margin
Net income